(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 3.41% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.06%.
Masimo's revenue in 2026 is $1,715,100,000.On average, 12 Wall Street analysts forecast MASI's revenue for 2026 to be $89,057,727,442, with the lowest MASI revenue forecast at $85,029,181,267, and the highest MASI revenue forecast at $91,958,280,688. On average, 11 Wall Street analysts forecast MASI's revenue for 2027 to be $95,825,685,016, with the lowest MASI revenue forecast at $90,991,429,606, and the highest MASI revenue forecast at $99,370,805,650.
In 2028, MASI is forecast to generate $101,358,221,763 in revenue, with the lowest revenue forecast at $97,383,389,537 and the highest revenue forecast at $104,312,488,958.